News & Updates
Filter by Specialty:
Esketamine outperforms quetiapine in head-to-head depression trial
In patients with treatment-resistant depression, esketamine nasal spray appears to have superior efficacy compared with extended-release quetiapine when used in combination with conventional antidepressants.
Esketamine outperforms quetiapine in head-to-head depression trial
30 Oct 2023
Adult ADHD spells increased dementia risk
Adults with attention-deficit/hyperactivity disorder (ADHD) face a nearly threefold higher risk of dementia compared with those who do not have the neurodevelopmental condition, according to a study.
Adult ADHD spells increased dementia risk
22 Oct 2023
Postpartum depression more common in pregnant women with rheumatic disease
Women of reproductive age with axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), or rheumatoid arthritis (RA) are more likely to experience postpartum depression than those without any rheumatic disease (RD), according to a study.
Postpartum depression more common in pregnant women with rheumatic disease
19 Oct 2023
Antipsychotic dose reduction in recurrent psychosis: No clear benefits but increased relapse risk
Gradual antipsychotic dose reduction does not provide benefits in social functioning and is associated with an increased risk of relapse in patients with schizophrenia, the RADAR trial has shown.
Antipsychotic dose reduction in recurrent psychosis: No clear benefits but increased relapse risk
09 Oct 2023
COVID vs non-COVID ARDS: Are both mentally distressing for patients’ kin?
Mental health symptoms of family members of patients hospitalized for acute respiratory distress syndrome (ARDS) were similar at 12 months regardless of whether it was caused by COVID-19 or not, a prospective cohort study suggests.
COVID vs non-COVID ARDS: Are both mentally distressing for patients’ kin?
04 Oct 2023
Pill pause linked to adverse mental health symptoms in long-term contraceptive users
For long-term users of combined oral contraceptives (COC), short-term hormonal withdrawal that occurs during the once-a-month pill pause appears to be accompanied by a significant increase in negative affect, anxiety, and mental health symptoms, regardless of COC type, as reported in a study.
Pill pause linked to adverse mental health symptoms in long-term contraceptive users
01 Oct 2023
Mindfulness therapy reduces IBS symptoms, improves life quality
Mindfulness-based stress reduction therapy (MBSRT) in patients with irritable bowel syndrome (IBS) results in improved quality of life and mindfulness components, as well as reduced IBS symptoms, when compared with controls, a study has shown.
Mindfulness therapy reduces IBS symptoms, improves life quality
28 Sep 2023
Drug monitoring may prevent weight gain in ASD patients taking aripiprazole
A recent study exploring the relationship between aripiprazole pharmacokinetics (PK), side effects, and effectiveness in children and adolescents with autism spectrum disorder (ASD) has found that higher plasma levels correlate with greater weight gain.